Stockreport

Actuate to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Actuate Therapeutics, Inc. - Common stock  (ACTU) 
PDF CHICAGO and FORT WORTH, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceu [Read more]